Zhangzhou Pientzehuang Financials
| 600436 Stock | 233.11 0.65 0.28% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Operating Income | 3.4 B | 3.3 B |
|
|
Zhangzhou | Select Account or Indicator |
Understanding current and past Zhangzhou Pientzehuang Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Zhangzhou Pientzehuang's financial statements are interrelated, with each one affecting the others. For example, an increase in Zhangzhou Pientzehuang's assets may result in an increase in income on the income statement.
Please note, the presentation of Zhangzhou Pientzehuang's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Zhangzhou Pientzehuang's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Zhangzhou Pientzehuang's management manipulating its earnings.
Zhangzhou Pientzehuang Stock Summary
Zhangzhou Pientzehuang competes with China Petroleum, PetroChina, China State, China Railway, and China Railway. Zhangzhou Pientzehuang is entity of China. It is traded as Stock on SHG exchange.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | China Stock View All |
| Exchange | Shanghai Stock Exchange |
| ISIN | CNE000001F21 |
| Business Address | No 1 Hupo |
| Sector | Pharmaceuticals |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.zzpzh.com.cn |
| Phone | 86 59 6230 1955 |
You should never invest in Zhangzhou Pientzehuang without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Zhangzhou Stock, because this is throwing your money away. Analyzing the key information contained in Zhangzhou Pientzehuang's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Zhangzhou Pientzehuang Key Financial Ratios
Zhangzhou Pientzehuang's financial ratios allow both analysts and investors to convert raw data from Zhangzhou Pientzehuang's financial statements into concise, actionable information that can be used to evaluate the performance of Zhangzhou Pientzehuang over time and compare it to other companies across industries.| Revenue | 10.06 B | ||||
| Gross Profit | 3.96 B | ||||
| EBITDA | 3.6 B | ||||
| Net Income | 2.78 B | ||||
| Total Asset | 17.08 B |
Zhangzhou Pientzehuang Key Balance Sheet Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 8.8B | 10.2B | 12.5B | 14.6B | 17.1B | 17.9B | |
| Other Current Liab | 540.4M | 702.8M | 609.4M | 699.7M | 30.6M | 29.1M | |
| Other Liab | 94.0M | 148.7M | 159.9M | 160.9M | 185.1M | 194.3M | |
| Retained Earnings | 4.7B | 5.9B | 7.8B | 9.6B | 10.0B | 10.5B | |
| Accounts Payable | 260.6M | 239.9M | 387.0M | 464.9M | 673.1M | 706.8M | |
| Cash | 4.3B | 5.2B | 7.1B | 2.5B | 1.2B | 1.5B | |
| Other Assets | 153.2M | 396.0M | 466.8M | 440.3M | 506.4M | 531.7M | |
| Net Receivables | 695.4M | 509.5M | 612.3M | 744.4M | 911.7M | 957.3M | |
| Inventory | 2.1B | 2.2B | 2.4B | 2.6B | 3.4B | 3.5B | |
| Other Current Assets | 271.9M | 292.2M | 261.4M | 406.6M | 9.1B | 9.6B | |
| Total Liab | 1.8B | 1.9B | 2.4B | 2.8B | 3.2B | 3.3B | |
| Intangible Assets | 155.7M | 259.4M | 221.0M | 319.4M | 291.1M | 305.6M | |
| Net Tangible Assets | 6.5B | 7.6B | 9.5B | 11.0B | 12.7B | 6.8B | |
| Total Current Assets | 7.4B | 8.3B | 10.6B | 12.7B | 15.1B | 8.5B | |
| Short Long Term Debt | 696.8M | 718.4M | 775.8M | 971.0M | 989.9M | 765.8M | |
| Net Invested Capital | 7.3B | 8.6B | 10.5B | 12.3B | 14.4B | 9.9B | |
| Net Working Capital | 5.6B | 6.5B | 8.5B | 10.2B | 12.2B | 7.9B |
Zhangzhou Pientzehuang Key Income Statement Accounts
An income statement is very similar to a cash flow statement, but instead of showing net revenue minus expenses, it only includes earnings before interest and taxes (EBIT). This number does not have all of the same line items that are on a cash flow statement, but it leaves out non-cash expenses like depreciation and amortization. For example, if you bought $100 worth of goods from Walmart (WMT) using your debit card that has an interest rate of 20%, then paid off the balance at the end of the month with a credit card that charges 30% interest, you would have an income statement showing EBIT of $80 because your expenses are lower than the amount that went into your pocket.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Interest Expense | 31.1M | 27.4M | 32.9M | 38.0M | 37.3M | 39.2M | |
| Total Revenue | 5.7B | 6.5B | 8.0B | 8.7B | 10.1B | 10.6B | |
| Operating Income | 1.6B | 1.8B | 2.8B | 2.9B | 3.3B | 3.4B | |
| Cost Of Revenue | 3.2B | 3.6B | 4.0B | 4.7B | 5.4B | 5.6B | |
| Income Before Tax | 1.6B | 2.0B | 2.9B | 3.0B | 3.4B | 3.5B | |
| Net Income | 1.4B | 1.7B | 2.4B | 2.5B | 2.8B | 2.9B | |
| Income Tax Expense | 257.7M | 289.5M | 404.2M | 454.8M | 523.0M | 549.1M | |
| Minority Interest | 338.4M | 394.4M | (32.6M) | (50.6M) | (53.8M) | (51.1M) | |
| Research Development | 119.4M | 97.6M | 199.5M | 230.0M | 232.4M | 135.5M | |
| Gross Profit | 2.5B | 2.9B | 4.1B | 4.0B | 4.7B | 2.9B | |
| Ebit | 1.6B | 1.8B | 2.7B | 2.8B | 3.3B | 1.7B | |
| Tax Provision | 257.7M | 289.5M | 405.0M | 454.8M | 517.8M | 328.2M | |
| Net Interest Income | 40.3M | 63.4M | 87.5M | 55.2M | 4.9M | 4.6M | |
| Interest Income | 75.0M | 94.0M | 125.7M | 96.4M | 44.6M | 74.0M | |
| Ebitda | 1.7B | 2.1B | 3.0B | 3.1B | 3.6B | 2.3B |
Zhangzhou Pientzehuang Key Cash Accounts
Cash flow analysis captures how much money flows into and out of Zhangzhou Pientzehuang. It measures of how well Zhangzhou is doing because it can show the actual money that comes into and out of the Company from sales instead of measuring expenses against revenue to determine earnings. You have to read the cash flow statement in three sections. The first section shows how much money Zhangzhou Pientzehuang brought in, usually known as net revenue or sales. This is different from earnings because it does not include expenses when determining net revenue for use on this part of the cash flow statement. Next, are operating activities, which show how much money Zhangzhou had leftover after paying for its expenses. This number can be calculated in two ways: by subtracting the total of all operating expenses from net revenue or by adding up changes to cash and other assets or liabilities on this part of the statement. The third section is about investing activities, which shows what Zhangzhou Pientzehuang has done with the money that it received from the sale of assets or what it spent to acquire new ones. This section can be broken down into two parts: investing in existing businesses (in other words, buying more stock) and investing in non-business activities like paying off debt or making acquisitions.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Capital Expenditures | 65.4M | 419.0M | 92.2M | 175.4M | 164.1M | 87.1M | |
| Net Income | 1.4B | 1.7B | 2.4B | 2.5B | 2.8B | 2.9B | |
| Dividends Paid | 392.6M | 522.3M | 569.2M | 760.6M | 783.8M | 822.9M | |
| Change To Inventory | (429.6M) | (74.9M) | (261.6M) | (199.4M) | (758.8M) | (720.8M) | |
| Investments | 42.9M | 15.0M | 143.3M | (6.2B) | (2.1B) | (2.0B) | |
| Change In Cash | (401.8M) | 642.3M | (4.3M) | 3.8M | 218.4M | 172.6M | |
| Net Borrowings | 96.4M | (4.5M) | 23.1M | 164.1M | 188.7M | 198.2M | |
| Depreciation | 55.9M | 90.2M | 133.5M | 80.4M | 102.4M | 81.5M | |
| Change To Netincome | 29.7M | (37.0M) | 57.6M | 32.2M | 37.1M | 38.9M | |
| End Period Cash Flow | 1.8B | 2.4B | 2.4B | 2.4B | 2.5B | 2.3B | |
| Free Cash Flow | (944.8M) | 1.0B | 370.1M | 6.7B | 2.9B | 1.8B | |
| Other Non Cash Items | 37.1M | 43.1M | 52.1M | 46.2M | 61.9M | 47.4M |
Zhangzhou Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Zhangzhou Pientzehuang's current stock value. Our valuation model uses many indicators to compare Zhangzhou Pientzehuang value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Zhangzhou Pientzehuang competition to find correlations between indicators driving Zhangzhou Pientzehuang's intrinsic value. More Info.Zhangzhou Pientzehuang Pharmaceutical is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.58 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Zhangzhou Pientzehuang Pharmaceutical is roughly 1.71 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Zhangzhou Pientzehuang by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Zhangzhou Pientzehuang's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Zhangzhou Pientzehuang Systematic Risk
Zhangzhou Pientzehuang's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Zhangzhou Pientzehuang volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Zhangzhou Pientzehuang correlated with the market. If Beta is less than 0 Zhangzhou Pientzehuang generally moves in the opposite direction as compared to the market. If Zhangzhou Pientzehuang Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Zhangzhou Pientzehuang is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Zhangzhou Pientzehuang is generally in the same direction as the market. If Beta > 1 Zhangzhou Pientzehuang moves generally in the same direction as, but more than the movement of the benchmark.
Zhangzhou Pientzehuang Pharmaceutical Total Assets Over Time
Zhangzhou Pientzehuang December 1, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Zhangzhou Pientzehuang help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Zhangzhou Pientzehuang Pharmaceutical. We use our internally-developed statistical techniques to arrive at the intrinsic value of Zhangzhou Pientzehuang Pharmaceutical based on widely used predictive technical indicators. In general, we focus on analyzing Zhangzhou Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Zhangzhou Pientzehuang's daily price indicators and compare them against related drivers.
| Downside Deviation | 2.41 | |||
| Information Ratio | 0.037 | |||
| Maximum Drawdown | 19.64 | |||
| Value At Risk | (3.27) | |||
| Potential Upside | 5.54 |
Complementary Tools for Zhangzhou Stock analysis
When running Zhangzhou Pientzehuang's price analysis, check to measure Zhangzhou Pientzehuang's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zhangzhou Pientzehuang is operating at the current time. Most of Zhangzhou Pientzehuang's value examination focuses on studying past and present price action to predict the probability of Zhangzhou Pientzehuang's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zhangzhou Pientzehuang's price. Additionally, you may evaluate how the addition of Zhangzhou Pientzehuang to your portfolios can decrease your overall portfolio volatility.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |